24 results
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
receive repetitive or duplicative communications.
The audit committee oversees the procedures for the receipt, retention, and treatment of complaints
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
to more onerous FDA obligations once implemented via regulation, including adverse event reporting and record retention requirements, safety
8-K
EX-10.1
qazh6xbs54 uop
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-10.1
ug6pew9p60p4hdm
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
424B3
e6kb 1v93
23 Jun 23
Prospectus supplement
4:47pm
10-K
006redpnpx ia0q
15 Apr 22
Annual report
5:11pm
424B4
33rqq0 3cv
27 Jul 21
Prospectus supplement with pricing info
10:42am
S-1
EX-99.5
wg726pmg
4 Mar 21
IPO registration
4:01pm